Resonance Health Limited [ASX:RHT] share price and news 2022

Company Description

Resonance Health Limited (RHT) is an Australian healthcare company involved in the development and delivery of non-invasive medical imaging software and services. Their products are used by clinicians in the diagnosis and management of human diseases and by pharmaceutical companies in their clinical trials. The Company’s flagship products include FerriScan®, FerriSmart®, HepaFat-Scan®, and the recently developed HepaFat-AI.

Resonance Health Limited belongs to Health Care sector and under industry of Health Care Equipment. You can get more information about this company via their website:

This a small cap company with market cap of 73 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while Company PB is greater than both sector and market. On the other hand, Company Earning is greater than both sector and market.

Earnings PE PB PE growth
Company 3 0 7.17 0
Market 0.85 22.3 1.99 0.84
Sector 1.29 25.9 4.23 1.53

Dividend Growth Chart

The following chart shows you how rht dividend grows in the recent years.

No data